FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

79605009: 3 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    132068015 Three en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442100016 3 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442101017 3 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    3 Is a General adjectival modifier false Inferred relationship Some
    3 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Bromazepam 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Auranofin 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Hydromorphone hydrochloride 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Auranofin 3 mg oral capsule Has presentation strength numerator value False 3 Inferred relationship Some 1
    Warfarin sodium 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Risperidone 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule Has presentation strength numerator value False 3 Inferred relationship Some 1
    Oxybutynin hydrochloride 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Ivermectin 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely ropinirole hydrochloride 3 milligram/1 each conventional release oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely pomalidomide 3 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely flupentixol 3 milligram/1 each conventional release oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Glimepiride 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Glibenclamide micronised 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Estropipate 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 2
    Product containing only ethinylestradiol 0.03 milligram and drospirenone 3 milligram/1 each oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 2
    Eszopiclone 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Doxepin 3 mg oral tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Dinoprostone 3 mg vaginal tablet Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely prochlorperazine maleate 3 milligram/1 each conventional release buccal tablet (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule Count of base of active ingredient False 3 Inferred relationship Some
    Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Count of base of active ingredient False 3 Inferred relationship Some
    Product containing precisely ceftazidime (as ceftazidime pentahydrate) 3 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 3 Inferred relationship Some 1
    Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Prednisolone 3 mg/mL oral solution Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Ephedrine hydrochloride 3 mg/mL oral solution Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter conventional release solution for ear or eye drops Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Hydroxypropyl methylcellulose 0.32% conventional release eye drops Has concentration strength numerator value False 3 Inferred relationship Some 1
    Hypromellose 3 mg/mL eye drops Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) Count of base of active ingredient False 3 Inferred relationship Some
    Diflucortolone valerate 3 mg/g cutaneous ointment Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Heparinoid 3 mg/g cutaneous cream Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 2
    Diflucortolone valerate 3 mg/g cutaneous cream Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) Has concentration strength numerator value False 3 Inferred relationship Some 1
    Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops Has concentration strength numerator value False 3 Inferred relationship Some 1
    Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely disodium pamidronate 60 milligram/20 milliliter conventional release solution for injection vial Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely disodium pamidronate 90 milligram/30 milliliter conventional release solution for injection vial Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely ephedrine hydrochloride 30 milligram/10 milliliter conventional release solution for injection ampule Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 3 Inferred relationship Some 1
    Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream Has concentration strength numerator value False 3 Inferred relationship Some 2
    Product containing precisely adenosine 30 milligram/10 milliliter conventional release solution for infusion vial Has concentration strength numerator value False 3 Inferred relationship Some 1
    Product containing precisely adenosine 6 milligram/2 milliliter conventional release solution for injection vial Has concentration strength numerator value False 3 Inferred relationship Some 1

    Page 1 of 5 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start